BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
BEAT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading BEAT News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.15%80.880.6%$350.98m
ABTAbbott Laboratories
-0.09%44.770.9%$328.78m
ISRGIntuitive Surgical, Inc.
-0.29%746.189.1%$254.23m
EWEdwards Lifesciences Corporation
0.90%94.311.0%$235.28m
TMOThermo Fisher Scientific Inc.
-0.45%154.631.1%$229.54m
BSXBoston Scientific Corporation
-0.06%24.261.3%$206.98m
BDXBecton, Dickinson and Company
0.59%183.711.6%$163.60m
BAXBaxter International Inc.
-0.23%51.671.7%$159.10m
SYKStryker Corporation
-0.66%131.581.7%$152.10m
ZBHZimmer Biomet Holdings, Inc.
-0.78%120.432.0%$142.66m
MASIMasimo Corporation
-0.33%92.963.9%$124.64m
IDXXIDEXX Laboratories, Inc.
0.01%152.893.6%$116.44m
BCRC. R. Bard, Inc.
-0.36%248.681.9%$104.97m
XRAYDENTSPLY International Inc.
-0.53%62.323.1%$90.54m
COOCooper Companies, Inc.
-0.04%199.713.1%$88.39m

Company Profile

BioTelemetry, Inc. cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It also develops proprietary integrated patient management platform that incorporates wireless data transmission network. The company operates through operates through the following segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. BioTelemetry company was founded on April 22, 2013 and is headquartered in Malvern, PA.